Johnson & Johnson Earnings Narrowly Top But Dow Giant's Sales Guidance LightInvestors Business Daily • 01/22/25
J&J's stock surrenders early gains as weak sales guidance offsets earnings beatMarket Watch • 01/22/25
Johnson & Johnson Q4 Earnings Loom As FDA Approves Depression Drug: Will Long-Term Weakness Reverse?Benzinga • 01/21/25
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?CNBC • 01/21/25
Investors Who Lost Money on Johnson & Johnson Should Contact Levi & Korsinsky About an Ongoing Investigation - JNJAccesswire • 01/21/25
Bronstein, Gewirtz & Grossman, LLC Is Investigating Johnson & Johnson (JNJ) And Encourages Shareholders to ConnectAccesswire • 01/21/25
SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depressionPRNewsWire • 01/21/25
Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?The Motley Fool • 01/21/25
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold ForeverThe Motley Fool • 01/21/25
Johnson & Johnson (JNJ) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky InvestigatesAccesswire • 01/20/25
Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) Stockholders to Inquire about Securities InvestigationAccesswire • 01/20/25
ATTENTION JNJ SHAREHOLDERS: Investors who lost money on Johnson & Johnson are urged to contact Levi & Korsinsky about an ongoing investigationAccesswire • 01/19/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Johnson & Johnson (JNJ) and Encourages Investors to Learn More About the InvestigationAccesswire • 01/19/25
Shareholders That Lost Money on Johnson & Johnson (JNJ) Should Contact Levi & Korsinsky About Securities Fraud Investigation - JNJAccesswire • 01/17/25
Johnson & Johnson (JNJ) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationAccesswire • 01/17/25
Shareholder Rights Advocates at Levi & Korsinsky Investigate Johnson & Johnson (JNJ) Regarding Possible Securities Fraud ViolationsAccesswire • 01/17/25